It is postulated that cold atmospheric plasma (CAP) can trigger a therapeutic shielding response in tissue by creating a time-and space-localized, burst-like form of oxy-nitrosative stress on near-surface exposed cells through the flux of plasma-generated reactive oxygen and nitrogen species (RONS). RONS-exposed surface layers of cells communicate to the deeper levels of tissue via a form of the ‗bystander effect,' similar to responses to other forms of cell stress. In this proposed model of CAP therapeutics, the plasma stimulates a cellular survival mechanism through which aerobic organisms shield themselves from infection and other challenges.
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Introduction
This paper proposes a conceptual model of the therapeutic action of cold atmospheric plasma (CAP), especially in the context of tissue disinfection, wound healing and cancer treatment. Summaries and reviews of CAP therapeutics-plasma medicine-have been recently published. [1, 2] The responsible mechanisms are still just beginning to emerge. However, three clinical trials were conducted and two CAP devices received CE marking-regulatory approval for study-in Germany in 2013, both intended to be applied for chronic wounds, and especially for the treatment of venous ulcers. [1] It is therefore important to construct models of CAP therapeutics to assist in developing the field.
The proposal presented here should be viewed as a hypothesis, and it is based on experimental observations of CAP as well as recent developments in the understanding of the roles of RONS in ionizing radiation biology, lifespan, cancer and antimicrobial therapy, and generalized cellular stress response,.
The vision presented here is neither exclusive nor exhaustive: exceptions to the model are not difficult to imagine. Given the relatively early stage of development of the field of CAP therapeutics, mechanistic understanding is limited and any model inferred from this limited set of observations is necessarily provisional and incomplete. Nevertheless, even a limited model can be helpful in moving the field forward and it is in this spirit that the present model is offered.
The proposed model of CAP therapeutics is based on several assumptions and key observations. The first assumption is that CAP-generated RONS are usually the most important active species in CAP therapeutics. [2, 3] There is evidence that electric fields and photons from the plasma play some role in CAP therapeutics under some conditions, but most investigations imply or demonstrate the key role of 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   3 RONS. Most reports of the effects of CAP in cells conclude that the effects are mediated, at least in part, by intracellular RONS, usually detected using fluorescence probes. [2, [4] [5] [6] Addition of radical scavenging agents such as N-acetylcysteine (NAC) typically abrogates the effects, implicating RONS as active agents.
Counter-intuitively, intracellular RONS are often observed to last much longer than expected based on simple reaction-diffusion estimates. [7] Table 1 lists some of the major RONS created via CAP in air or in aqueous solution adjacent to CAP. Most of the listed species in Table 1 are radicals -that is, they have an unpaired electron in the outer shell. This configuration is generally chemically unstable and indeed, depending on the local reaction partners, the radicals listed in Table 1 will generally react quickly. Table. 1 Estimated half-lives of known CAP-generated RONS in physiological environments. [8] Radicals are denoted with a dot: -.‖ Note these half-life estimates can depend strongly on local environmental conditions such as pH and concentrations of reactive partners. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   4 significantly shrunk in murine models following CAP treatment, as reported by several authors. [4, 8, 9] The evidence therefore suggests that the biological effects of CAP can extend beyond the superficial layers of cells that are contacted directly by gas phase species and over times that can greatly exceed typical RONS lifetimes. Any model of CAP therapeutics must take these characteristic features into account.
Summary of proposed model
The relatively long time-and length-scale effects of CAP on biological tissue suggests the shortlived RONS act by triggering a series of longer acting biochemical and biological processes. The proposed model, named the ‗oxy-nitroso shielding burst' model, consists of the steps listed in Table 2 . Table 2 . Summary of proposed oxy-nitroso shielding burst model of CAP therapeutics.
1. A relatively short term ‗burst,' lasting perhaps several 10 -10 2 seconds of CAPgenerated, gas phase RONS, are exposed to and react with ~10 cm 2 of surface layer cells and/or fluids. These species generate longer-lived species, such as H 2 O 2 , various oxidized and nitrated/nitrosylated proteins, carbohydrates, peptides, amino acids, lipids, etc. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   5 in the local tissue. Further cell-cell communication may occur, as well as immune system stimulation or suppression and physiological modulation (e.g. blood flow augmentation). Time scales for these processes are on the order of tens of hours to days. 4 . The net result of the cellular response is similar to what is intended by the immune system: trigger and activate tissue repair and regeneration; protect against infection; and suppress tumors.
The perspective of this paper is that these CAP-induced processes mimic and/or stimulate natural processes, including the innate and even adaptive immune system, designed to protect, or shield, tissue from infection, disease and tumor formation. RONS are seen in this context as part of an ancient, evolutionarily conserved response that organisms use to protect themselves. CAP therapeutics, and other therapeutics as well, therefore both exploit and stimulate this natural shielding biochemistry. The remainder of the paper aims to elaborate, illustrate and provide evidence in favor of the proposed model. Figure 1 is a highly simplified schematic diagram exploring some of the ways that CAP, at least via the creation of RONS, may be affecting tissue. CAP creates gas phase reactive species that may first dissolve in aqueous fluid covering the surface layer of cells or perhaps they enter or activate cell membranes directly. RONS are, by definition, fairly short lived since they will react rapidly with other species in the gas phase, at surfaces and/or in an adjacent liquid phase. This raises the obvious question about their depth of penetration into tissue beyond the surface layer of cells before reacting to form a less reactive specie. For example, in a recent study of the role of the Ar jet plasma 'KINpen' in dermatology, investigators showed by skin histology and confocal microscopy that the apparent depth of altered skin (in the stratum corneum) was ~ 5-10 microns. [10] [11] [12] These authors suggest that the main 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   6 effect of the plasma was due to oxidative radicals as a decrease in carotene antioxidants was observed. In some cases, deeper penetration was observed in the vicinity of hair follicles on the skin. [11] Partecke et al. showed using both in vitro and in vivo models of pancreatic cancer cell lines that their ‗tissue tolerable plasma' (TTP; KINpen09; Ar plasma jet) resulted in apoptosis in cancer cells to a depth of about 50 µm.
Superficial nature of direct CAP-tissue interactions
[13] These authors suggest that this may limit CAP cancer treatment to treating, intra-operatively, resected tissue boundaries. A similar suggestion was made by Walk et al. in their studies using He plasma jets in a murine model of neuroblastoma. [9] A recent study by Szili et al. utilized a He plasma jet impacting a gelatin gel model of tissue with encapsulated RONS ‗reporters.' These authors found a surprisingly deep penetration of RONS of up to 1.5 mm in their gel model of tissue, suggesting that biological effects of CAP may be promoted by more physical transport effects, perhaps related to charges and fields associated with plasma-tissue 6 interactions. [14] By contrast, Barekzi and Laroussi suggest that in the context of plasma cancer treatment, -...the plasma triggers some sort of biochemical reactions that require time to induce internal cellular effects that can lead to cell death.‖ [15] The question of the depth of CAP therapeutic effectiveness is still clearly a matter of intense research, and these aspects of the model presented here will be refined as more complete information becomes available.
If CAP treats a liquid medium that is in turn applied to a tissue surface as illustrated in Fig. 1 , the active species in the liquid phase are unlikely to penetrate the tissue much deeper than several cell layers.
It is true that lifetimes are longer for relatively unreactive compounds formed in liquid solution, such as nitrate (NO 3 -), nitrite (NO 2 -), hydrogen peroxide (H 2 O 2 ), organic peroxides (RO 2 •) or some other species created by reaction with a reactive plasma-generated specie. In some cases (e.g. nitrite anion), reaction rates are strongly affected by pH. Table 1 lists the approximate lifetimes of various reactive species, known to be created in CAP, in biological liquid phases. The more reactive components, likely to be most active, are the ones with the shortest lifetime that can penetrate the shortest distance before reacting. 5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   7 While these are crude estimates of diffusion distances, the basic question remains : how can CAP affect tissue deeper than superficial surface layers? Figure 1 suggests several possibilities, including cell-cell ‗bystander' communication; activation of the immune system; and/or local blood flow modifications. Each of these possibilities is briefly addressed in subsequent sections of this article. But before we turn to that, it should be noted that secondary reaction products-those created when reacting with the original RONS-will often, if not generally, be longer lived. For example, the nonenzymatic antioxidants vitamin C (ascorbate) and vitamin E (α-tocopherol) will both form relatively stable radicals when reacting with RONS or with lipid peroxides (sometimes denoted LOO.) created by RONS reactions. Other common secondary reaction species (oxidative stress ‗markers') following lipid peroxidation include various aldehydes, most notably malondialdehyde (MDA) and 4-hydroxy-2-nonenal (HNE). RONS-biomolecule reaction products that are electrophilic (e.g. nitrated lipids) can form adducts with proteins that can affect gene expression and inflammation. [16] Kalghatgi et al. appear to have been the first to point out that organic hydroperoxide secondary reaction products of RONS (e.g. from amino acids and proteins in cell culture medium) are longer lived than the original RONS and that these species likely play a role in spatially and temporally extending the effects of the localized reactions between CAP and near-surface cells. [5] The direct effects of CAP are probably mainly active in the near-surface cellular region of the tissue; our understanding of this aspect of the model will no doubt evolve with additional research.
Radicals and reactive species in biology
If RONS are important parts of CAP biomedicine, what is known about these species in a [ [20] [21] [22] These three publications in the mid-1950s set the stage for several decades of research into the effects of radicals and other RONS, so they are worth a summary before addressing how the original ideas have changed over the years.
The 1954 paper of Commoner, Townsend and Pake was the first to actually measure radicals in biological samples (albeit freeze-dried or lyophilized versions). They employed electron paramagnetic resonance spectroscopy, a tool that is still the major instrument for the direct measure of unpaired electrons in radical species. In addition to the work of Michaelis on electron-transfer reactions and redoxinduced radicals, it was known that ionizing radiation and some chemicals could also create radicals in biological tissue. Commoner to show similar signs of damage. [21] Since it was well established that the major damage done by radiation was due to oxidizing radicals, they postulated that the damage observed from O 2 poisoning and ionizing radiation were both the result of oxygen-related radicals. They conducted additional experiments showing rabbits exposed to high oxygen concentrations were somewhat protected when they were given compounds known to protect against radiation; and mice exposed to radiation died faster when they were simultaneously exposed to high O 2 atmospheres. Both sets of results supported their hypothesis of the similar and even synergistic mechanisms of cellular damage resulting from high O 2 concentration and radiation. These authors also cite Michaelis (and others) suggesting that radicals form naturally in biological systems due to oxidative metabolism.
Harman published his now-famous article two years later and he cited the work of Commoner et al. in showing the presence of radicals in biological tissue, especially those associated with metabolic processes as predicted by Michaelis. [19, 20, 22] Harman was most interested in the causes of aging and his postulate was that OH and HO 2 radicals were the common cause of cellular damage due to ionizing radiation and natural metabolic and related oxidizing enzymatic-and iron-catalyzed processes.
Furthermore, the similarities between radiation damage and aging suggested to Harman that radicals with their cumulative, uncontrolled damaging reactions with many biological molecules and connective tissue may be the central cause of human aging and degenerative diseases. The original theory was extended in 1972 to focus specifically on free radical reactions occurring in the mitochondria, since it is well known that the majority of reactive oxygen species created in cells are generated during parts of the respiratory electron transport chain. [23] This theory launched decades of active research and had an enormous impact on biomedicine for this period. For a more complete history of the sequence of biochemical discoveries concerning RONS, see the reviews of Niki; Valko et For decades after the original article by Harman, evidence accumulated in the literature about the correlation between higher than normal levels of oxidative and nitrosative stress with not only aging but also many chronic diseases. The connection between RONS and these diseases has usually been made through detection of modified (oxidized, nitrated, etc.) proteins and lipids present in patients with the disorders in question. [25, 28] The diseases includes cancer; cardiovascular disease; diabetes; atherosclerosis; rheumatoid arthritis; Alzheimer's; Parkinson's; and ischemia/reperfusion injury, among others. [25, 26] One influential publication in the mid-1990s referred to the oxygen paradox: -...that higher aerobic organisms cannot exist without oxygen, yet oxygen is inherently dangerous to their existence.‖ [29] The fact that oxidative (and nitrosative) stress is associated with so many diseases suggested to researchers for many years that one attractive therapeutic option is to somehow deliver antioxidants in higher concentrations and/or more effectively localized to the specific sites where they are needed, in order to counter this apparent imbalance. However, recent large scale clinical trials have shown this practice is not effective and may even be counter-productive. [30] Furthermore, there is now widespread acceptance of the idea that RONS play many important roles in normal physiology, especially at lower concentrations. [25] Under this point of view, the potentially pathological effects of RONS is generally associated with excessively high concentrations and/or relatively long exposure times. Reactive species are now known to play essential roles in immunity and inflammation; cell cycle; metabolism; cell differentiation, development and death; vascular tone and blood pressure; neurotransmission and platelet activation; protein post-translational modification; and transcription factor modification and gene expression, among others. [26] The ‗two-faced character' and ‗dual roles' played by RONS have been widely and repeatedly documented in the literature. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 11 Indeed, these multiple roles are likely important reasons why virtually all aerobic organisms actively generate and use RONS as a key part of their generalized stress response. [31] A corollary of the model presented here is that the successful therapeutic actions of CAP highlighted in the literature over the last several years follow from this connection: that is, exogenous, relatively short term application of RONS in appropriate dosages can be helpful to counter infection, disease and other conditions. But before turning to the main proposal of this article regarding CAP therapeutic mechanisms, a brief review of the current state of understanding of RONS and aging will set the stage.
Longevity, RONS, and mitohormesis
As noted above, decades of research suggested that radicals and oxidative stress are the main trigger and fundamental cause of aging and probably many degenerative diseases as well. This perspective has changed gradually over the years and is now openly contradicted, at least by some researchers. [32] For example, the recent publication of Hekimi et al. summarizes the case against the strict version of the Free Radical Theory of Aging (FRTA) succinctly, noting the following points (excluding the references in the original text): [33] (i) a lack of correlation between the level of ROS production and longevity in various species; (ii) deleterious rather than beneficial effects on life-span from the administration of antioxidants in various species from invertebrates to humans; (iii) that the inactivation of over-expression of antioxidant activities in several genetically engineered organisms fails to produce outcomes that support the FRTA; (iv) the existence of long-lived mutants and species with high ROS production and high levels of oxidative damage. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   12 Hekimi et al. note that there is, however, generally clear evidence of increasing oxidative damage as organisms age. [33] They offer an alternative hypothesis that invokes the cellular generation and use of ROS as a signaling response to stress. As the organism ages, in this model, ROS generated to initiate stress response can itself start to create damage. In this vision, ROS are therefore not the initial cause of aging, but they progressively contribute to the damage associated with the aging process. This seems consistent with the available evidence, but the role of RONS in aging remains an area of active research with a variety of interesting hypotheses that must be systematically tested. [34] The significance of this RONS/aging literature for CAP therapeutics goes beyond the observation that RONS are not always damaging and are probably not the initiating cause of aging. This literature has also led to a better understanding of the mechanisms by which RONS might actually be life extending and healthy. This is the topic of RONS hormesis, sometimes referred to as ‗mitohormesis,' since it generally involves RONS created in the mitochondria. The recent review by Ristow and Schmeisser lays out the theory of mitohormesis and summarizes the published evidence supporting it in a particularly complete manner. [35] perhaps most effectively promoted by Calabrese has been defined as -an overcompensation to a disruption in homeostasis.‖ [36] It therefore is intrinsically a transient process and biological feedback response is at its heart: the biological system senses a disruption and tries to re-establish homeostasis and this results in an ‗overshoot,' or overcompensation. Figure 3 makes an analogy between mitohormesis (ROS dose leads to an eventual reduction in ROS) and vaccination (low dose of infectious agent leads to an eventual reduction in infectious agents), both leading to lifespan enhancing outcomes. [35] The simplified diagrams 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 13 shown in Figs. 2 and 3 are not meant to be rigorous descriptions of highly complex biological processes, but should be taken as illustrations of the qualitative concepts. The evidence for mitohormesis is based on observations of adaptive biochemical signaling in response to stressors including caloric restriction (CR), hypoxia, temperature stress, and physical activity. These stresses, if they are not too large, result in enhanced metabolic activity, resulting in increased ROS formation, and ultimately an adaptive response that increases defense mechanisms and improves health. In the case of moderate exercise, subjects taking antioxidant supplements at the time of the exercise lost some of the healthy benefits of the exercise. [35] Another important element supporting the concept of mitohormesis and the ultimately positive effects of transient pro-oxidant conditions is the recent literature on the likely effects of phytochemicals in the diet. [37] Phytochemicals originate in plants and are generally thought to have positive health effects.
Well-known examples include sulfurophane (from broccoli); the spice curcumin; diallyl sulfides (from garlic and onions); various green tea components; and resveratrol (from red wine). These compounds are observed to result in positive (antioxidant, anti-inflammatory) responses at low doses, but harmful effects at higher doses. The compounds appear to work in a manner similar to exercise: as low dose pro-oxidants they stimulate a hormetic adaptive response that is ultimately antioxidant and health-inducing.
In concluding this section, there appears to be a growing consensus that RONS (and therefore conditions and/or foods that are pro-oxidant) can act in a way that aids the health of the organism. It does this through the organism's own inherent adaptive stress response mechanisms. That is, transiently increasing RONS triggers processes that ultimately results in lower steady state RONS concentration in the tissue, and also an enhanced overall stress responsiveness to other, subsequent stresses. This crucially important issue of generalized adaptive stress response, or cross-stress adaptation, will be addressed later.
Also addressed in greater detail later is the implication -and evidence in practice -that cross-resistance in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 14 response to CAP-generated RONS might lead to undesirable adaptation by microbes or tumors. The idea that CAP therapy can be interpreted in the context of hormesis was suggested by Brun et al. in their study of He/O 2 plasma jets interacting with ocular cells. [38] 6. Oxidative shielding vs. oxidative stress An evolutionary perspective on the issue of RONS and cellular stress response is provided in the provocative review by Naviaux.
[39] Naviaux argues that an ancient, evolutionarily conserved role for mitochondria is cellular defense. No cells in the ancient Precambrian seas survived without effective defenses against viruses and bacteria, so evolution selected cells that were able to protect themselves. He points out that mitochondria are highly sensitive to small changes in cellular redox state since they are the primary oxygen sink in the cell. If a eukaryotic cell is infected by an endoparasitic bacterium or virus, this endoparasite will, as it attempts to grow, 'steal' electrons and other nutrients from the cell, immediately altering the cellular redox potential and disrupting cellular metabolism. The cell uses less oxygen as a result of this disruption in metabolism, the oxygen concentration in the cell starts to rise, and a higher rate of ROS generation occurs. But this response has an essentially protective effect, first for the infected (or damaged) cell if it can be saved, but if the cell must be sacrificed (e.g. via programmed cell death, or apoptosis), then for the organism as a whole. Naviaux refers to this process as 'oxidative shielding.' [39] Cell division and macromolecular synthesis are inhibited under these conditions and the cellular membrane becomes less permeable, keeping other microbes from entering the cell and not allowing the ones that have invaded the cell to get out and infect other cells. Furthermore, proteins such as lipoxgenases, NF-κB, and NADPH oxidases are formed, and the innate-immune system is activated. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 15 Milisav et al. (2012) point out that changes in the cellular redox potential increase the rate of damaged macromolecule removal by the ubiquitin-proteasome pathway and autophagy, arrest cellular growth and division, and up-regulate the production of molecular chaperones via the induction of heat shock factors and other stress-related transcriptional regulators. [40] As noted previously, Naviaux points out that an infected cell with an altered cellular redox state may undergo RONS-induced apoptosis in order to avoid the spread of the infection. The objective, in short, is to save the organism, not necessarily the infected or damaged cell . Naviaux argues that 50 years of focus on oxidative stress leading to disease and aging is mostly misplaced. He concludes by writing: [39] ROS and oxidative changes in chronic disease are the symptoms of disease and not the cause... Membrane lipid peroxidation, fibrosis, protein oxidation, and hundreds of other markers that were formerly cataloged as oxidative damage need to be understood as cellular oxidative shielding. The conserved pathways of oxidative shielding are protein-catalyzed reactions that evolved as the first steps in innate immunity. They evolved to protect the cell from chemical and microbial threats in the environment. Both oxidative and reductive stress will trigger cellular oxidative shielding. Oxidative shielding takes many forms in different bacterial, plant and animal phyla. All forms ultimately increase membrane rigidity, decrease membrane permeability, and inhibit cell division.
In many ways, Naviaux's concept of oxidative shielding (generalized here as oxy-nitroso shielding for CAP therapeutics) is an attractive model for interpreting the many positive effects seen with CAP in wound healing, disinfection, tumor shrinkage, etc. The idea is that CAP-generated RONS trigger a natural, evolutionarily conserved mechanism for organismal protection that relies initially on the mitochondria and their ability to sense minute changes in cell redox potential and associated changes in cell metabolism. In effect, CAP-generated RONS and/or their immediate reaction products trigger and then amplify a natural 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   16 protective mechanism. But if the externally applied RONS induce a protective cellular response only near the surface of the tissue (cf. Fig. 1 ), how might this information be propagated to the rest of the tissue?
Transmitting the effects of CAP to adjacent and distant cells
There are three suggested means for transporting the effects of CAP to the deeper cells in the tissue shown in Fig. 1 : cell-cell communication (e.g. ‗bystander effect' in radiation biology); immune system activation; and changes in blood flow. The focus in this section will be on the first mechanism as it has received considerable attention in the context of ionizing radiation and in the radiation biology literature.
And as will be discussed in greater detail below, the bystander effects mechanisms appear to overlap considerably with immune system activation.
Radiation-or radio-therapy employing ionizing radiation has a number of physiochemical effects in common with CAP therapeutics, and the radio-therapy literature is therefore a promising source of inspiration for CAP therapeutic mechanisms. Both approaches can generate RONS in exposed cells; both single strand and double strand breaks in DNA can be observed following CAP and radiotherapy; and cells will undergo apoptosis or even necrosis after sufficiently high exposures. This is not to say that the two approaches are identical; RONS generated via CAP are created in the gas phase and must move somehow into treated cells whereas ionizing radiation (IR) easily penetrates into tissue. Even different wavelengths of radiation will have profoundly different biochemical effects. For example, Ward points out that UV radiation and ionizing radiation differ considerably in their biological targets, DNA damage and effects on gene transcription.
[41] So we do not expect that cellular response to IR and CAP will be the same; however, the similarities between the two suggest a closer look might provide some useful hypotheses. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   17 Another important feature that may be common to both approaches is that the RONS observed in exposed cells may be primarily the result of cellular, or endogenous, processes. That is, they are not necessarily the direct result of ionizing radiation creating RONS in the cellular cytosol or the gas phase CAP-induced RONS entering the cells. Ward observed that at levels of radiation fluence (or dose) in therapeutic applications, the rate of RONS directly created by incident photons is relatively small compared to the background levels from, for example, the electron transport chain in mitochondria. [41] Mikkelson and Wardman note that when ionizing radiation interacts with cellular cytoplasm (and not directly with DNA), cellular mechanisms amplify considerably the levels of RONS observed to be present, and this appears to be part of a generalized cellular stress response. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 18 irradiated tissue. [47] Furthermore, RONS are known to play a central role in cell cycle progression, depending on concentration and time of exposure. [48] Stressed cells will stop the normal cell cycle in order to engage in repair or alternatively proceed to apoptosis or necrosis and RONS play a role in this process. Figure 5 illustrates the concept that ionizing radiation can cause cells to either undergo apoptosis or adaptation and survival. Surviving cells are thought to be either (or both) the result of the RIBE (radiation induced bystander effect) and/or radiation induced adaptive response (RIAR). [45] It is not yet clear if there is a difference between these responses, hence the distinction. But both responses share similarities to innate immunity, especially involving RONS as part of the cellular signaling process.
Klammer et al. point out that modulation of RONS and cellular redox may be a tool multi-cellular
organisms use to respond to external stresses by forcing cells to either adapt or die. [45] This seems close to Naviaux's ideas about oxidative shielding. [39] And it is related to other concepts now emerging regarding stress adaptation, discussed in the next section.
Adaptive stress response, cross-resistance, and preconditioning
RONS are known to be central to the generalized cellular stress response (CSR). For example, Kultz states that redox potential changes are major triggers of the CSR, and that almost all genes known to be activated in response to stress are also affected by redox potential and reactive species. [49] RONS generated in the cell in response to stress act as potent intracellular messengers, thereby playing a positive role in CSR in spite of the obvious damage they can cause to specific macromolecules. In responding to 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 19 stress, cells can adapt themselves in such a way that they are protected against future stresses that may be even greater; this is referred to as ‗cross-resistance.' Figure 6 (following Milisav et al.) illustrates the idea.
[40] The fact that cross-resistance can result from RONS-related stress is crucially important for the oxynitroso shielding model of CAP therapeutics. Only if the stress adaptation induced by exposure to CAP can protect against a multitude of threats, including those that require the cell to undergo apoptosis (e.g. A particularly interesting and medically important example of this principle is ischemic preconditioning. Ischemia occurs when tissue is deprived of blood flow and therefore oxygen. When blood flow is resumed (termed ‗reperfusion'), the result is generally very damaging to the tissue; this sequence is referred to as ‗ischemia/reperfusion' injury or ‗I/R.' This is the source of major damage to heart and brain tissue during heart attacks and ischemic strokes, respectively. The tissue damage is thought to be primarily mediated by excessive RONS that appear during reperfusion. [50] Ischemic preconditioning occurs when the tissue is subjected to brief periods of ischemia prior to a major I/R event.
There is overwhelming evidence that ischemic preconditioning protects the tissue from major I/R injury.
[51] Animals given antioxidants prior to ischemic preconditioning experienced less protection than those not given antioxidants, suggesting that the protective mechanism involves the brief increase in RONS   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 20 levels induced during the preconditioning stage. [52] This seems related to the antioxidant-induced reduction in beneficial effects of exercise, noted above, in the discussion on RONS-stimulated hormesis.
Of particular interest to CAP therapeutics, ozone exposure has been shown to have an active preconditioning effect in various situations. Ajamieh et al. reported that ozone preconditioning had a similar effect as ischemic preconditioning for liver I/R injury. [ An observed phenomenon that seems related to the mechanism by which oxidative preconditioning mimics ischemic preconditioning is ‗ROS-induced ROS release' (RIRR) from mitochondria. [57] Zorov et al. describe how ROS released by mitochondria can travel to adjacent mitochondria, inducing them to release ROS as well, and that this ROS amplification process somehow terminates at some point. These ROS are thought to -…activate local pools of redox-sensitive enzymes,‖ in order to -… limit ischemic damage to cells in that area.‖ [57] The role of mitochondrial ROS is emphasized by Silachev et al. [58] :
Under certain conditions when tissues are repeatedly exposed to small doses of ROS and within short time frames, greater tolerance (ischemic preconditioning) to a larger and sustained exposure to ROS is conferred, thus limiting infarct size after a stroke or myocardial ischaemic injury. The adaptive mechanisms providing ischemic tolerance involve ROS of mitochondrial origin.
Yan refers to this effect as ‗positive oxidative stress.' [59] He has identified protein redox modification (protein reaction with RONS) as a central mechanism through which this process occurs. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 21 [60] The implication is that exogenously applied RONS, for example from CAP, might form similarly redox modified proteins and that these modified proteins act as ischemic preconditioning agents.
Indeed, there is evidence that something like this might occur with ozone, as noted above.
Exogenously applied ozone appears to act to induce a similar or identical oxidative stress as ischemia, and the ozone-induced preconditioning effect may be very similar or the same as if the tissue experienced a brief period of ischemia. Ozone can also be introduced into the body by mixing the proper concentrations with blood that has been taken from a patient, then re-introduced. In this way, ozone was shown to act as a hormetic agent able to counter various ischemia-related problems. [61] The possible role of ozone application in altering blood flow directly is addressed below.
Oxy-nitroso shielding in existing therapies
The concept of CAP-generated RONS acting in a manner analogous to existing therapies was advanced and discussed in detail previously, so only a brief summary is included here for completeness. [3, 62] Anti-cancer agents (other than CAP) that act by raising tumor oxidative stress include radiotherapy [63] ; photodynamic therapy [64] ; many chemotherapeutic drugs [65, 66] ; and hyperthermia [67, 68] . Antiinfective drugs, including many antibiotics [69] ; antifungals [70] ; and anti-parasitics [71] are known to act, at least in part, by raising oxidative stress in infected cells. From the perspective of this article, these drugs may act by triggering or initiating endogenous RONS and achieve their therapeutic effects via oxynitroso shielding, thus matching part of the cell's own stress response mechanism that can lead to either cellular apoptosis or adaptation. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   22 Another important aspect that has been largely unaddressed is the issue of negative or undesirable aspects of stress adaptation in certain therapies. Noted above in the context of radiation (radio-) therapy is the distinction between radiation induced bystander effect (RIBE) and radiation induced adaptive response (RIAR). The implication of the adaptive response is that tumor cells may become resistant to further radiotherapy. A similar resistance to therapeutic chemotherapy often develops. Furthermore, these forms of resistance often occur together and both forms of resistance appear related to cellular adaptation to oxidative stress. [72] In the context of cancer therapy this is an undesirable form of stress adaptation and cross resistance. The interplay and contrast between desirable and undesirable forms of stress adaptation is by no means clear at present; the topic is discussed further in a later section of the paper. The potentially re-sensitizing role of CAP-generated nitrosative stress as a potential advantage of CAP for cancer therapy was discussed in a recent review. [62] 
Immune system implications
Naviaux argues that the ancient, evolutionarily conserved cellular creation of RONS as shielding responses to infection or damage is similar to, and indeed was the precursor for, the innate immune response now seen throughout aerobic biology. [39] Klammer et al. specifically note the similarity between IR-induced bystander effects and cell-cell communication known to occur in innate immunity.
[45] The mechanism is proposed to be ligand-induced pattern recognition receptors in cellular membranes.
These are known to be either pathogen-associated molecular patterns (PAMPs; e.g. lipopolysaccharide associated with gram negative bacterial membranes) or damage-associated molecular patterns (DAMPs).
DAMPs result from tissue injury and can include high-mobility-group box 1 (HMGB1) protein; S100 protein; heat shock proteins; proteins oxidized by ROS (including oxidized DNA fragments; see e.g. [47] ); 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 23 cellular debris; and cytokines of the IL-1 family, among others. [73] Such responses are also known to follow tissue injury and are sometimes termed ‗sterile inflammation. ' Chovatiya and Medzhitov make the important point that although outright inflammation has been traditionally viewed as a defense response to either infection or tissue injury, recent research shows that milder inflammatory-like reactions can also be induced by tissue stress. [74] Furthermore, tissue responses to maintain and restore homeostasis manifest as a spectrum: from stress response (for the mildest deviations from homeostasis) to para-inflammation and finally to full inflammation for the most aggressive insult. [74] These authors point out that cell response to stress is both cell-autonomous (i.e. endogenous: acting on the stressed cell) and non-autonomous (i.e. exogenous: acting on other cells). Cells such as macrophages and sensory neurons are reported to be even more sensitive to stress signals than regular cells.
The implication for CAP-generated RONS therapy and oxy-nitroso shielding is that these intrinsic mechanisms of sensing stress activate established, evolutionarily-conserved tissue-level protective responses. In such inflammatory (or inflammatory-like) reactions, it is crucially important that the response be both temporary and localized. Sustained (or systemic) inflammation can be damaging (and potentially life-threatening) and is associated with many diseases. Innate immune response in invertebrate animals involves the so-called ‗respiratory burst,' in which local O 2 consumption increases, and (mostly) immune cells (leukocytes) such as neutrophils and macrophages generate various RONS to combat infection and activate tissue repair mechanisms. In plants, an analogous response, serving a similar purpose, is termed the ‗oxidative burst.' [75] In mammalian systems, these immune system generated RONS serve both direct and indirect purposes: countering local microbes and acting as signaling molecules to attract leukocytes. For example, recently it has been shown that H 2 O 2 concentration gradients 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   24 extending several hundred microns from a wound site in zebrafish act to attract phagocytic leukocytes to the site of the wound. [76] Locally and temporarily increasing RONS concentration at the site of damage or infection is the first, rapid response of innate immunity across all of aerobic biology. CAP-generated RONS share the local and temporary (burst-like) nature of innate immune response. It is possible that CAP therapeutics act in the same manner as natural responses to infection and injury.
In addition to innate immune effects associated with IR, there is increasing evidence for synergy between radiotherapy and immunotherapy in which the adaptive immune system comes into play. [77] [78] [79] The recognition of a connection between radiotherapy and the adaptive immune system stemmed from observation of the ‗abscopal effect,' in which tumor irradiation leads to shrinkage of a tumor far from the site of irradiation. This non-local effect is now strongly associated with an adaptive immune response.
The idea is that local tumor irradiation induces ‗immunogenic cell death,' meaning that the tumor cells die in a way that stimulates an immune response. Fomenti and Demaria provide details, but briefly, it is established that cellular release of calreticulin, HMBG1 and ATP are sufficient to trigger the response.
[79] These agents induce dendritic cell maturation, tumor antigen uptake and T cell activation. This leads to the adaptive immune response as lymphocytes recognize and attack tumors throughout the body. By combining radiotherapy with immune enhancing drugs (conventional immune therapy), a synergistic effect is observed. [77] In effect, IR acts as an adjuvant to activate or sensitize the immune response. A similar mechanism has been proposed to explain immune system activation in photodynamic therapy (PDT), an anti-cancer technology that also employs reactive oxygen species. PDT induces necrosis in tumors through the interaction of red light with a photosensitizer (primarily localized in the tumor), generating excited oxygen (O 2 singlet delta) from (dissolved) ground state O 2 . [80] Hence, the nominally local treatments of radiotherapy and PDT are known to potentially have systemic components. There does 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 25 not appear to be any evidence yet that a similar coupling may take place between CAP therapy and the adaptive immune system, but it should be investigated further.
CAP effects on blood flow and blood O 2 content
The third proposed way (cf. Fig. 1 ) that local CAP treatment might lead to non-local effects is via enhanced blood flowrate and O 2 content of blood in the vicinity of CAP application. Collet et al. showed that a several minute long, He plasma jet application to the external skin of a mouse induced a substantial increase in subcutaneous blood O 2 content and blood flow that lasted for several hours. [81] Furthermore, the effect was limited to tissue near the part of the skin exposed to the plasma. The same effect was observed when gauze impregnated by de-ionized water was placed between the plasma jet and skin, suggesting a dissolved component is involved. Mechanisms are not understood at present, but one RONSrelated possibility is that known vasodilating specie like nitric oxide, most likely in the form of nitrite anion, is generated in the plasma and transported through skin. [82] Another possibility is related to ozone, which is often created in CAP operated in air. Topically applied gaseous ozone was used during World Wars I and II for promoting wound healing, and it was reported in 1940 that one effect of ozone application to slowly healing wounds is an increase in local capillary blood flow. [83, 84] Both mechanisms are speculative, clearly, but the fact that recent studies report blood flow/O 2 content effects suggests that they should also be investigated further. [81] 12. Evidence for the model 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   26 Although the experimental evidence to date is incomplete and therefore inadequate for a full test of the proposed model, there have been enough preliminary reports to begin to get an idea of its legitimacy (cf. Table 2 ). Some of the most important aspects of the model follow directly from the widely reported characteristics of CAP therapeutics. Most investigators have reported observing intracellular RONS following CAP treatment and these effects can last much longer than the expected lifetime of the RONS themselves. For example, Zhao et al. report detecting intracellular RONS 24 hours after exposing in vitro cells to CAP. [7] This is consistent with the part of the proposed model that stresses the importance of the biological response following the initial RONS-induced shielding burst response. Furthermore, the ability of CAP treatment (acting through skin) to shrink sub-cutaneous tumors in murine models also suggests that some indirect cell-to-cell communication effects are probably involved. [8, 9, 85] Many authors have shown that in vitro CAP effects are often mediated through the liquid cellsustaining medium. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   27 change. [88] The proposal that cellular stresses induced by CAP treatment might lead to a similar cell-cell communication bystander response thus seems to be a reasonable proposal, although no direct evidence for this has been reported in the literatures, to the author's knowledge. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   28 inflammatory responses induced by IR associated with the bystander effect. [45] Ahn et al. and Panngom et al. both report the importance of cellular mitochondrial damage following CAP exposure. [93] This is consistent with Naviaux's prediction that oxidative shielding occurs via redox perturbation, sensed in mitochondria. [39] The model proposes that CAP treatment, mediated by cellular RONS (either endogenous or exogenous), will result in a hormetic response in tissue: stimulative and/or adaptive at lower doses and damaging at higher doses. The fact that CAP can be used to induce a wound-healing and anti-infective response at lower dose and anti-tumor responses at higher doses is consistent with this model. The success, noted above, of applied O 3 to mimic ischemic preconditioning via oxidative stress is consistent with hormesis as well. As noted previously, Brun et al. already suggested the perspective of CAP acting in a hormetic fashion to protect cells from infection. [38] RONS-induced stress adaptation is a central feature of the proposed model, but not all aspects of this phenomenon are necessarily positive in terms of CAP therapeutics, as noted previously. There are preliminary hints that undesirable adaptation to oxy-nitroso stress might occur following CAP exposure.
Ishaq et al. demonstrate that the main difference between CAP-sensitive and CAP-resistant in vitro colorectal cancer cells is the absence or presence, respectively, of an active antioxidant system. [94] It is well known that cancer cell chemo-and radio-resistance are coupled and related to antioxidant activity (e.g. [95] [96]), so since cancer cells can develop resistance following these conventional pro-oxidant therapies, might they not do the same thing following CAP treatment? In any case, the adaptive response of the targets of CAP therapeutics may employ the same (or similar) stress adaptation mechanisms to protect themselves from RONS stress. Nathan and Shiloh, among many others, have documented evidence showing microbial RONS resistance genes and corresponding enzymes. [97] More recently, Dwyer et al. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49 29 detail evidence that bacterial responses to antibiotics often involve generation of ROS and that these bacterial ROS can contribute to bactericidal action of antibiotics. [98] They note that there appears to be a dual function for these bacterial metabolism-generated ROS: at low stress levels, they lead to (bacterially-) beneficial mutations (i.e. stress adaptation) but at high levels, they lead to death when stresses are large.
Testing the model
Well-designed experiments could provide evidence to evaluate, refine or refute the hypotheses put forth by this model:
1. The model proposes that CAP therapeutic shielding effects are mainly due to products of RONS reacting with proteins, lipids, carbohydrates, peptides, and amino acids. If this is accurate, then the effects of plasma treatment of tissue should be reproducible by exposing tissue to a synthetic mixture of the major RONS reaction products formed in cell culture medium or cellular fluids.
2. Cells stressed with CAP-generated RONS or RONS products should adapt or die in a dosedependent fashion, thereby following the pattern of a hormetic response.
3. Cells that hormetically adapt to CAP-generated RONS or RONS products should show crossresistance to other stresses. 4 . If cell-generated, soluble, diffusible signaling molecules are responsible for a CAP-mediated bystander effect, cell culture medium exchange experiments should demonstrate induction of the oxynitroso shielding response by an ATR-dependent pathway in cells that have not been directly treated. 8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49   30 These signaling molecules should be associated with the innate immune response. 
RONS-induced cell

Summary and concluding remarks
This paper proposes a model of the main mechanisms of CAP therapeutics: the oxy-nitroso shielding burst model. In this model, relatively short-lived reactive oxygen and nitrogen species created in the gas phase plasma enter the liquid/biological fluid phase and react to form longer lived species such as H 2 O 2 and oxidized and/or nitrated/nitrosylated proteins, peptides, amino acids, lipids and related biomacromolecules. Exposure times are short relative to most biological dynamics -typically only a few minutes; areal exposures are also limited to spatially confined regions of typically a few cm 2 or perhaps slightly more. These species may enter, or at least are sensed by, near-surface cells in the exposed tissue.
This burst application of RONS mimics innate immune responses to infection or injury and is proposed to initiate a bystander effect-like cell-cell communication of stress. The major biological effects of CAP therapeutics are proposed to follow from this initial burst-like trigger. The keys to the model are: (1) RONS and their reaction products should be seen as protective or shielding compounds, inducing either cell stress adaptation or cell death, both of which can be beneficial to the tissue as a whole; (2) the biological effects are probably often transported away from the initial treatment site by various mechanisms related to the immune system and possibly enhanced blood flow;
and (3) the intra-and inter-cellular signaling mechanisms induced by CAP therapy both mimic and are amplified by natural cellular redox modulation mechanisms.
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